Institutional members access full text with Ovid®

Share this article on:

The impact of hypoxia on nephrogenesis

Buchholz, Bjoern; Schley, Gunnar; Eckardt, Kai-Uwe

Current Opinion in Nephrology & Hypertension: May 2016 - Volume 25 - Issue 3 - p 180–186
doi: 10.1097/MNH.0000000000000211
RENAL IMMUNOLOGY AND PATHOLOGY: Edited by Agnes B. Fogo

Purpose of review: Kidney development depends on outgrowth of the ureteric bud into the metanephric mesenchyme. The number of ureteric bud branching events determines the final number of nephrons, which correlates inversely with the risk for development of chronic kidney disease and arterial hypertension during lifetime. The purpose of this review is to highlight the influence of oxygen on nephrogenesis and to describe cellular mechanisms by which hypoxia can impair nephron formation.

Recent findings: Although kidney development normally takes place under hypoxic conditions, nephrogenesis is impaired when oxygen availability falls below the usual range. Hypoxia-inducible factors (HIF) play an important role in linking low oxygen concentrations to the biology of nephron formation, but their effect appears to be cell type dependent. In ureteric bud cells, HIF stimulates tubulogenesis, whereas HIF stabilization in cells of the metanephric mesenchyme results in secretion of growth factors, including vascular endothelial growth factor A, which in aggregate inhibit ureteric bud branching. The balance between pro and antibranching effects may be altered in various ways, but the inhibitory effect usually seems to predominate under reduced oxygen concentrations, explaining how intrauterine hypoxia can lead to low nephron numbers.

Summary: Oxygen availability has a complex influence on nephrogenesis. Oxygen concentrations outside an optimal low range may affect nephron endowment. Associations between placental insufficiency and increased risk for chronic kidney disease and arterial hypertension during later life may to a large extent be due to direct effects of reduced oxygen supply to the metanephric mesenchyme and mediated through the HIF pathway.

Department of Nephrology and Hypertension, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany

Correspondence to Kai-Uwe Eckardt, MD, Department of Nephrology and Hypertension, Friedrich-Alexander University Erlangen-Nürnberg, Ulmenweg 18, D-91054 Erlangen, Germany. Tel: +49 9131 8539002; fax: +49 9131 8539209; e-mail: Kai-Uwe.Eckardt@uk-erlangen.de

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.